As we ramp for a great 2017 we are looking back on what we did in 2016. As we ramp for a great 2017 we are looking back on what we did in 2016. In that spirit, here are the top 5 blog posts of 2016 by views.
FDA Introduces a New Test Concept: “Complementary Diagnostics”
FDA-Approved Biomarker Panels: The Good, The Bad, and The Ugly
Biomarkers and Commercial Strategy: Comparing The Three Leading Breast Cancer Panels
10 Diagnostics Innovators: Smaller Companies Are Leading the Way
Introducing the Personalized Medicine Scorecard™: Drug Companies Edition